Loading...
OTC Markets
Totals
Securities
12,304
Dollar Vol
$2.5B
Share Vol
3.8B
Trades
319,611

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

BTCY
Biotricity Inc.

Common Stock

0.52

0.0513

10.95%

0.52 / 0.5685 (9000 x 1000)

Real-Time Best Bid & Ask: 05:00pm 06/13/2025
Delayed (15 Min) Trade Data: 03:30pm 06/13/2025

Biotricity Inc.

203 Redwood Shores Parkway

Suite 600

Redwood City, CA 94065

Business Description
Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. To learn more, visit www.biotricity.com.
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0001630113
Fiscal Year End
3/31
Company Officers & Contacts
Waqaas Al-Siddiq
President, CEO

Board of Directors
Waqaas Al-Siddiq
Chairman, President, CEO

Jainal Bhuiyan
Independent Director

Ronald Wayne McClurg
Independent Director, Audit Committee Member, Nominating Committee Member

Ronald McClurg has served as Chief Financial Officer of the Company since January 2021. Prior to joining the Company, from October 2003 to June 2019, Mr. McClurg served as Vice President - Finance & Administration and Chief Financial Officer of Incisive Surgical, Inc., a privately-held medical device manufacturer. From 1997 to 2002, Mr. McClurg served as Chief Financial Officer and Treasurer of Wavecrest Corporation, a privately-held manufacturer of electronic test instruments for the semiconductor industry. Prior to 1997, Mr. McClurg served as Chief Financial Officer for several publicly-held companies, including Video Sentry Corporation, Insignia Systems, Inc., and Orthomet, Inc. Currently, he serves on the board of governors of Biomagnetic Sciences, LLC. He began his career in public accounting with Ernst & Young, where he earned his CPA certificate. He holds a Bachelor of Business Administration degree in accounting from the University of Wisconsin - Eau Claire.

Dave Rosa
Independent Director, Audit Committee Member, Compensation Committee Member

Other Company Insiders

None

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers
Accounting/Auditing Firm
SRCO Professional Corporation, Charted Accountant

15 Wertheim Court, Suit 409

Richmond Hill, ON L4B 3H7

Canada

Securities Counsel
Sichenzia Ross Ference Carmel LLP

1185 Avenue of the Americas,

31st Floor

New York, NY 10036

Profile Data
SIC - Industry Classification
3841 - Surgical and medical instruments
Incorporation Information
NV, US, 2012
Employees
39 as of 07/19/2024
Shell
No
Products and Services

Company Vision Biotricity believes the future of healthcare is in connected medical devices that produce data leveraged by both physicians and individuals. We envision that these devices will be further integrated with big data, predictive AI, and machine intelligence to create better and faster analytics for better and faster care delivery. Company Mission At Biotricity our mission is to hold an individual’s hand throughout their cardiac journey. Today, cardiac care is disjointed and there exists no set of solutions that deliver complete care. We are meticulously and strategically expanding our portfolio with solutions that can stand alone and operate together to create a cohesive view of an individual’s health.

Company Facilities

203 Redwood Shores Pkwy Suite 600 Redwood City, CA 94065

Company Notes
Formerly=MetaSolutions, Inc. until 2-2016
OTCQB Venture Market Logo
Joined OTCQB 08/2024
The Company Profile data was verified by the issuer within the previous 6 months.
This security is not a Penny Stock as defined in SEC Rule 240.3a51-1.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Daily Advancers
    Subscribe to Our Newsletter
    Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.